Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
With the rapid evolvement of fluorescence imaging in oncology, non-targeted fluorochromes are currently under investigation for clinical use. Here we investigated if the degree of tumour angiogenesis can be assessed in vivo by planar and tomographic methods using a perfusion-type cyanine dye (SIDAG).
